March 11, 2026

Kainova reports positive top line results from Phase I EPRAD trial

​Kainova Therapeutics has reported positive top line results from the Phase I EPRAD study of DT-9081 in patients with advanced,...

March 10, 2026

Building for decades: Dubai’s long game in life sciences

​Dubai is building life sciences clusters and research hubs, aiming to be a resilient healthcare and innovation center in a...

March 10, 2026

GE HealthCare secures FDA 510(k) clearance for diagnostic viewer

​GE HealthCare has received 510(k) clearance from the US FDA for View, the diagnostic viewer within its Genesis Radiology Workspace.The...

March 10, 2026

AbbVie reports topline data from Phase I ABBV-295 trial

​AbbVie has reported positive topline data from the multiple ascending dose (MAD) section of its Phase I trial of ABBV-295...

March 10, 2026

NewcelX and Eledon partner for NCEL-101 programme

​NewcelX has signed a collaborative research agreement with Eledon Pharmaceuticals to advance its NCEL-101 programme for type 1 diabetes.The post...

March 9, 2026

LifeVac receives FDA De Novo classification for anti-choking device

​LifeVac has received De Novo classification from the US FDA for its suction anti-choking device under 21 CFR 874.5400.The post...

March 9, 2026

Aisa Pharma reports positive results for AISA-021

​Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 for patients with SSc RP.The post...

March 9, 2026

BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment

​BMS has received the US FDA approval for Sotyktu, an oral selective TYK2 inhibitor, to treat adults with active psoriatic...

March 6, 2026

Cognita secures FDA breakthrough device designation for CXR

​Cognita has received the FDA breakthrough device designation for the Chest X-Ray (CXR) model across multiple critical indications.The post Cognita...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.